s6y

425 Merger communication

Filed
Accession number
0001213900-26-080417

Documents

  1. Current Report 425

Exhibits

  1. 10.1 Amendment No. 1 to Securities Purchase Agreement, Dated as of July 22, 2026, by and Among Mentari Therapeutics, Inc. and the Investors Party Thereto EX-10.1
  2. 99.1 Press Release, Issued on July 22, 2026 EX-99.1

On sec.gov